Moffitt Cancer Center

Covance, M2Gen to promote faster patient recruitment in biomarker-driven oncology trials

Tuesday, February 26, 2013 09:35 AM

Covance, a Princeton, N.J.-based provider of drug development services, has entered into an exclusive alliance and services agreement with M2Gen, a subsidiary of the Moffitt Cancer Center and developer of personalized cancer treatments.

More... »


First MDS consortium to conduct trials and research to improve patient outcomes

Thursday, June 14, 2012 09:23 AM

Taussig Cancer Institute at Cleveland Clinic will participate in an unprecedented, six-institution consortium designed to conduct clinical trials and research to improve outcomes for patients with myelodysplastic syndrome (MDS).

More... »


Modulation Therapeutics receives $500,000 from MMRF for cancer treatment

Monday, June 11, 2012 11:54 AM

The Multiple Myeloma Research Foundation (MMRF) has awarded $500,000 through its Biotech Investment Award (BIA) program to Modulation Therapeutics, an early-stage pharmaceutical company which has licensed MTI-101 from the Moffitt Cancer Center.

More... »

Newly patented trial-patient pairing system promises to accelerate cancer trials

Wednesday, February 15, 2012 03:38 PM

A new patent has been issued to Moffitt Cancer Center for a computerized system that efficiently selects the right patient for the right clinical trial.

More... »

Moffitt, The US Oncology Network advance cancer patient services

Thursday, October 27, 2011 12:57 PM

Moffitt Cancer Center,  the only National Cancer Institute(NCI) Comprehensive Cancer Center in Florida, and The US Oncology Network will work together to expand access to patient services in Florida. As part of both organizations’ long-term commitment to advancing the quality and science of cancer care, the two are collaborating to develop and operate community-based cancer centers throughout the state.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs